All filters
Videos
Prospects for cure | Annemarie Wensing, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
What is the place of the monoclonal antibodies in the clinic | Julià Blanco, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Reduced drug regimens | Andrea De Luca, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
What’s in the pipeline? Presentations by scientists from the industry | Jean-Marc Steens, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
What’s in the pipeline? Presentations by scientists from the industry | Jean-Marc Steens, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
What’s in the pipeline? Presentations by scientists from the industry | Kathleen Squires, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
What’s in the pipeline? Presentations by scientists from the industry | Kathleen Squires, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Management of hepatitis C therapy failures - clinical perspective | Sanjay Bhagani, BSc FRCP
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Novel simplified bioinformatics for NGS data analysis | Marc Noguera-Julian, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
New technologies reaching the clinic | Martin Däumer, MSc
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Implications for clinical practice | Jonathan Schapiro, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Clinical trial data 3 vs 2 drug regimens | Andrea De Luca, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Influence of resistance in the future | Richard Harrigan, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
The current status of PrEP in Europe | Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
A new wild-type HIV in the era of transmitted drug resistance | Kristof Theys, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Long acting HIV drugs for prevention: what are the data? | Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCP
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
Improving drug delivery: what are the new technologies? | Saye Khoo, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
How would the epidemic evolve in the future | David van de Vijver, PHARMD, PHD
Presented at:
European Meeting on HIV & Hepatitis 2018
Videos
The HIV epidemic in CEE countries | Oana Săndulescu, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018